182 related articles for article (PubMed ID: 21262116)
1. Exertional rhabdomyolysis after influenza A (H3N2) infection in a basketball player boy.
Sevketoglu E; Kural B; Beskardes AE; Hatipoglu S
Ann Trop Paediatr; 2011; 31(1):93-6. PubMed ID: 21262116
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
[TBL] [Abstract][Full Text] [Related]
4. Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy.
Piralla A; Gozalo-Margüello M; Fiorina L; Rovida F; Muzzi A; Colombo AA; Alessandrino PE; Baldanti F
J Clin Virol; 2013 Sep; 58(1):132-7. PubMed ID: 23810646
[TBL] [Abstract][Full Text] [Related]
5. Optimum timing of oseltamivir: lessons from Bangladesh.
Ison MG
Lancet Infect Dis; 2014 Feb; 14(2):88-9. PubMed ID: 24268592
[No Abstract] [Full Text] [Related]
6. Prolonged shedding of amantadine- and oseltamivir-resistant influenza A(H3N2) virus with dual mutations in an immunocompromised infant.
Ruiz-Carrascoso G; Casas I; Pozo F; González-Vincent M; Pérez-Breña P
Antivir Ther; 2010; 15(7):1059-63. PubMed ID: 21041923
[TBL] [Abstract][Full Text] [Related]
7. The course of fever following influenza virus infection in children treated with oseltamivir.
Suzuki E; Ichihara K
J Med Virol; 2008 Jun; 80(6):1065-71. PubMed ID: 18428131
[TBL] [Abstract][Full Text] [Related]
8. A case of H3N2 complicated by acute kidney injury secondary to rhabdomyolysis.
Gonakoti S; Bahirwani J; Maddala RNM; Vidyasagar S
BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29669772
[TBL] [Abstract][Full Text] [Related]
9. Myopericarditis and exertional rhabdomyolysis following an influenza A (H3N2) infection.
Tseng GS; Hsieh CY; Hsu CT; Lin JC; Chan JS
BMC Infect Dis; 2013 Jun; 13():283. PubMed ID: 23786640
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
[No Abstract] [Full Text] [Related]
11. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.
Sugaya N; Mitamura K; Yamazaki M; Tamura D; Ichikawa M; Kimura K; Kawakami C; Kiso M; Ito M; Hatakeyama S; Kawaoka Y
Clin Infect Dis; 2007 Jan; 44(2):197-202. PubMed ID: 17173216
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychiatric events in an adult patient with influenza a (H3N2) treated with oseltamivir (Tamiflu): a case report.
Chen R; Fang Z; Huang Y
BMC Infect Dis; 2019 Mar; 19(1):224. PubMed ID: 30832611
[TBL] [Abstract][Full Text] [Related]
13. Rhabdomyolysis following pandemic influenza A (H1N1) infection.
Chen SC; Liu KS; Chang HR; Lee YT; Chen CC; Lee MC
Neth J Med; 2010 Aug; 68(1):317-9. PubMed ID: 20739729
[TBL] [Abstract][Full Text] [Related]
14. The virologist and the flu.
Wicker S; Rabenau HF
J Clin Virol; 2015 Aug; 69():200-2. PubMed ID: 26209407
[TBL] [Abstract][Full Text] [Related]
15. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
Abed Y; Baz M; Boivin G
J Infect Dis; 2009 Jan; 199(2):180-3. PubMed ID: 19046066
[TBL] [Abstract][Full Text] [Related]
16. Influenza-associated mortality in hospital care: a retrospective cohort study of risk factors and impact of oseltamivir in an English teaching hospital, 2016 to 2017.
Reacher M; Warne B; Reeve L; Verlander NQ; Jones NK; Ranellou K; Christou S; Wright C; Choudhry S; Zambon M; Sander C; Zhang H; Jalal H
Euro Surveill; 2019 Oct; 24(44):. PubMed ID: 31690364
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyolysis induced by influenza A infection: case report and review of literature.
Sato E; Nakamura T; Koide H
Ther Apher Dial; 2011 Apr; 15(2):208-9. PubMed ID: 21426516
[No Abstract] [Full Text] [Related]
18. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
[TBL] [Abstract][Full Text] [Related]
19. Global transmission of oseltamivir-resistant influenza.
Moscona A
N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
[No Abstract] [Full Text] [Related]
20. [Successful Treatment of Seasonal Influenza A (H3N2) infection-related Hemophagocytic Lymphocytosis in an Elderly Man].
Suzuki S; Tanaka A; Fukuda Y; Miyata Y; Murata Y; Kishino-Oki Y; Homma T; Ohnishi T; Sagara H
Kansenshogaku Zasshi; 2016 Jan; 90(1):77-82. PubMed ID: 27032178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
